v3.22.4
CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Dec. 31, 2020
CASH FLOWS FROM OPERATING ACTIVITIES      
Net income $ 328,196 $ 224,915 $ 97,061
Adjustments to reconcile net income to net cash provided by operating activities:      
Depreciation and amortization 130,757 104,808 73,270
Amortization of convertible notes debt discount 1,851 7,987 7,187
Stock-based compensation expense 21,751 22,887 15,960
Deferred income taxes (9,349) (3,943) 8,091
(Gain) loss on sale of property, plant and equipment (5,560) 583 91
Other 4,785 4,971 3,900
Change in operating assets and liabilities, net of acquisitions of businesses:      
Trade and other receivables, net 26,056 (14,350) (29,190)
Inventories (11,896) (232,465) (34,554)
Prepaid expenses and other assets 20,123 (13,114) (2,414)
Accounts payable, accrued liabilities and other (94,976) 149,851 20,751
Net cash provided by operating activities 411,738 252,130 160,153
CASH FLOWS FROM INVESTING ACTIVITIES      
Capital expenditures (79,883) (64,804) (32,100)
Proceeds from sale of property, equipment, facility and other 7,620 197 211
Business acquisitions, net of cash acquired (248,899) (508,127) (305,995)
Other investing activities (305) (2,000) 0
Net cash used in investing activities (321,467) (574,734) (337,884)
CASH FLOWS FROM FINANCING ACTIVITIES      
Term debt borrowings 0 58,750 0
Term debt repayments (7,500) (6,875) (5,000)
Borrowing on revolver 839,436 832,500 239,277
Repayments on revolver (894,147) (972,500) (99,277)
Proceeds from senior notes offering 0 350,000 0
Proceeds from convertible notes offering 0 258,750 0
Purchase of convertible notes hedges 0 (57,443) 0
Proceeds from sale of warrants 0 43,677 0
Cash dividends paid to shareholders (32,869) (27,024) (23,630)
Stock repurchases under buyback program (77,117) (48,940) (23,106)
Taxes paid for share-based payment arrangements (10,227) (17,814) (3,741)
Payment of deferred financing costs (2,464) (15,745) (58)
Payment of contingent consideration from business acquisitions (5,580) (1,600) (2,000)
Proceeds from exercise of common stock options 195 4,950 643
Net cash (used in) provided by financing activities (190,273) 400,686 83,108
(Decrease) increase in cash and cash equivalents (100,002) 78,082 (94,623)
Cash and cash equivalents at beginning of year 122,849 44,767 139,390
Cash and cash equivalents at end of year $ 22,847 $ 122,849 $ 44,767